By: Tone Southerland
Introduction
The CMS-0062-P proposed rule represents a pivotal moment in our industry’s journey toward true interoperability. Building on the foundational work of CMS-0057-F and finalizing several “optional” FHIR® Implementation Guides, this regulation moves the needle significantly toward a connected, efficient healthcare ecosystem. At HealthLX, we view this as a landmark opportunity to address long-standing challenges in administrative burden. We commend CMS for its inclusion of Requests for Comment (RFCs) throughout the proposal, signaling a continued commitment to active industry dialogue. Our stance is simple: we support the direction of this rule and are dedicated to advancing interoperability in a way that is both meaningful and achievable for the entire health plan community. While the proposed rule’s implications for pharmacy and drug prior authorization are currently generating significant industry discussion, this post focuses on the broader strategic implications for interoperability.
Our commitment to these standards is not just theoretical. In June, HealthLX submitted formal comments to CMS regarding this proposed rule (as we did for CMS-0057-P over three years ago), sharing implementation-based insights on everything from streamlining API standards to optimizing pharmacy-benefit drug workflows. You can review our full perspective and recommendations in our public comment at Regulations.gov.
Industry Leadership and Advocacy
As a founding member of the HL7 Da Vinci Project and a leading organization driving national interoperability standards, HealthLX is uniquely positioned to interpret the practical implications of CMS-0062-P. We do not just advocate for standards; we build the real-world solutions that bring them to life. Our approach centers on a critical balance: implementing future-proofed architectural designs that meet the vision of CMS while respecting the realistic timelines and operational realities our customers face every day. We see these compliance driven mandates as an opportunity to rethink and adapt existing workflow to ultimately achieve better operational performance, leading to reduced costs and burden on payers, providers, and patients, and ultimately improving health outcomes for all.
Benefits for Health Plans
The benefits of CMS-0062-P extend far beyond simple compliance. By extending electronic prior authorization to drugs and adopting FHIR standards under HIPAA, health plans have the opportunity to drastically reduce administrative overhead.
- Operational Efficiency: By streamlining prior authorization, plans can move away from manual, fax-heavy processes toward automated, FHIR-based workflows.
- Financial Impact: Increased member engagement—facilitated by improved data transparency and efficient prior authorization—directly correlates to reduced health plan expenses and lower operational friction.
- Beyond Pharmacy: This rule is not just about pharmacy benefits; it is about scaling interoperability across the entire CMS-0057 framework. It introduces new components applicable to all exchange paradigms, ensuring that a health plan’s investment in FHIR is leveraged across the entire enterprise, not siloed into a single department.
Strategic Approach
We advocate for an iterative and incremental approach to interoperability. Rapid, massive overhaul is rarely the most stable path. By phasing in standards, we ensure that adoption does not alienate or over-burden smaller health plans that may lack massive technical infrastructure.
Success requires more than just internal focus; it demands proactive coordination with PBMs and delegated entities.
HealthLX actively supports our customers by bridging these gaps, supporting compliance across the entire health plan exchange paradigm. We help plans navigate the complexity of these relationships, ensuring that whether a healthcare service or drug is categorized as a medical or pharmacy benefit, the provider receives a seamless, clear decision pathway.
Conclusion
The path forward is clear: we must continue to prioritize the shared goal of achieving better healthcare outcomes for all. CMS-0062-P is a significant step, and by embracing a strategic, incremental approach to interoperability, we can turn these regulatory requirements into a competitive advantage for health plans. If you are looking to navigate these changes and move toward a more efficient future, HealthLX is ready to help. Contact us today to learn how our interoperability services can support your organization’s journey.